Stryker pleads guilty to selling unapproved devices, to pay $80 mln
December 08, 2014 at 13:56 PM EST
Dec 8 (Reuters) - Medical device maker Stryker Corp will pay the U.S. government $80 million to settle charges that its OtisMed Corp subsidiary sold devices used in knee replacement surgery without approval from the U.S. Food and Drug Administration.